The HCPLive migraine page is a comprehensive resource for clinical news and insights on migraine headaches. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for migraines, and more.
March 14th 2023
Data from a phase 2 randomized clinical trial demonstrate use of the GLP-1 receptor agonist exenatide could be used as a treatment for idiopathic intracranial hypertension in women.
Migraine with Aura Increases Risk of Stroke
February 18th 2016Patients who suffer from migraine with aura are more than twice as likely to experience an ischemic stroke than the general population, according to new research presented at the American Stroke Association’s International Stroke Conference 2016 in Los Angeles, California.
Low Back Pain Also Raises Your Risk for Migraine
Risk of developing migraines is increased for those who have low back pain, a low level of education, a heavy physical workload, or participate in heavy recreational activities, but is decreased for those who drink alcohol frequently.
Migraine Risk Higher in Patients with Low Back Pain
The risk of developing migraine is increased for those who have low back pain, a low level of education, a heavy physical workload, or participate in heavy recreational activities, but is decreased for those who drink alcohol frequently.
Treating Migraine through the Trigeminal Ganglion
Research has established that various parts of the trigeminal system are responsible for peripheral symptoms of migraine. Treatment with corticosteroids reduces the symptoms of migraine, but the treatment is associated with long-term side effects.
Stress from Migraines Can Cause More Migraines
Stress resulting from frequent migraine headaches may contribute to the development of medical and psychological comorbidities that can result in an ugly cycle of more migraines, according to a study in the Journal of Pain Research.
Cluster Headache Remains an Enigma Despite Clinical Clues
A recent study in The Journal of Headache and Pain sheds some additional light on the chronobiological experience of patients with cluster headache (CH). However, it still leaves lingering mysteries around the pattern of pain CH that patients typically experience, the triggers of those headaches, and the mechanisms and interactions that drive headache frequency and severity.
Chronic Migraine: Study to Look at Long-Term Use of OnabotulinumtoxinA
A recently completed Phase III trial – called PREEMPT – established the efficacy and safety of onabotulinumtoxinA (marketed by Allergan under the brand name Botox®) in treating chronic migraine. Following those results, a new long-term trial is currently underway to analyze some of the clinical questions raised but not answered in PREEMPT.
Understanding the Relationship between Chronic Pain and Obesity
Both chronic pain conditions and obesity are major and increasing public health concerns, and the connections between the two have been firmly established in the medical literature. But as the prevalence of obesity worldwide continues to grow, a deeper understanding of this connection could potentially benefit both practitioners and patients.
Vagal Nerve Stimulation Device Shows Promise in Treating Chronic Migraine
Treatment for patients with chronic migraine is notoriously elusive. Pharmacologic options are few and only two medications-topiramate and onabotulinumtoxin-have shown significant treatment effect in clinical research to date. As with most pain maladies, however, medication isn't the only treatment avenue.
New Drug Deemed Effective for Opioid-Induced Constipation
July 1st 2015With 259 million painkiller prescriptions written in 2012 alone, according to the Centers for Disease Control and Prevention (CDC), one of the most common side effects experienced by patients being treated for chronic pain is opioid-induced constipation (OIC).